Skip to main content

Table 1 Before and after matching sample characteristics

From: Assessing the outcomes of implantable cardioverter defibrillator treatment in a real world setting: results from hospital record data

 

Sub-sample 1

Sub-sample 2

 

Before matching

After-matching

Before matching

After-matching

 

Mean case (sd)

Mean control (sd)

Standardized difference

Mean case (sd)

Mean control (sd)

Standardized difference

Covariates

      

Age

65.90 (12.02)

70.40 (10.09)

−0.01

66.30 (10.58)

70.12 (9.83)

−0.01

Gender (Female)

0.15 (0.35)

0.16 (90.38)

0

0.14 (0.35)

0.15 (0.35)

0

Charlston Index = 0

   

0.53 (0.49)

0.54 (0.50)

0

Charlston Index = 1

   

0.24 (0.43)

0.30 (0.46)

0

Charlston Index = 2

   

0.14 (0.35)

0.21 (0.41)

0

Outcomes

      

LOS

9.15 (11.9)

9.05 (9.72)

0.152

8.86 (11.24)

9.07 (9.40)

0.154

Re-hospitalization rate

2.11 (3.51)

1.54 (2.52)

0.202

2.14(3.60)

1.57(2.42)

0.227

Mortality

0.29 (0.45)

0.47 (0.50)

−0.109

0.30 (0.46)

0.46(0.50)

−0.067

Expenditure for index hospitalisation (€)

15020.92 (5780.23)

4259.72 (5780.95)

1.44

14815.56 (7343.40)

4307.13(6443.55)

1.347

Total hospital expenditure during follow up (€)

24944.31 (19558.93)

10881.34 (13230.06)

0.156

24829.44 (19863.8)

11269.01 (14044.27)

0.618

Patients

1050

11976

 

905

5962

 
  1. Legend: Sub-sample 1: ICD and non ICD patients with the same primary diagnosis (+ other controls); Sub-sample 2: ICD and non ICD patients with the same primary diagnosis and Charlson index (+ other controls; Case: Patients with ICD; Controls: Patients without ICD; Standardized difference = After-matching standardized differences between case and control groups; LOS = Length of Stay in day.